MICA and NKG2D variants as risk factors in spondyloarthritis: a case-control study
Marie Fechtenbaum1,2, Judith Desoutter3, Gauthier Delvallez3
1Department of Rheumatology, Amiens University Medical Center, Amiens, France. marie.fechtenbaum@wanadoo.fr.
Abstract:
The major histocompatibility complex class I polypeptide-related sequence A (MICA) glycoprotein mediates the activation of the natural killer group 2D receptor (NKG2D) expressed on NK and CD8+ T cells. A methionine or valine at position 129 in exon 3 results in strong (MICA129 met) or weak (MICA129 val) binding to NKG2D. The MICA A5.1 allele causes a premature stop codon. Various NKG2D polymorphisms are associated with low (NKC3 C/C and NKC4 C/C) or high (NKC3 G/G and NKC4 T/T) levels of NK cell cytotoxic activity. In 162 patients with spondyloarthritis (115 with ankylosing spondyloarthritis, 46 with psoriatic arthritis and 1 with reactive arthritis) compared to 124 healthy controls, MICA-129 with methionine allele was more frequent in patients with spondyloarthritis (odds ratio (OR) (95% confidence interval) = 4.84 (2.75‒8.67)), whereas MICA-129 val/val, MICA A5.1 and NKC3 C/C variants were less frequent (OR = 0.20 (0.11‒0.37), 0.15 (0.06‒0.36) and 0.24 (0.13‒0.44), respectively). After adjustment for HLA-B*27 status, only NKC3 C/C remained linked to spondyloarthritis (adjusted OR = 0.14 (0.06‒0.33)). Homozygosity for MICA A5.1 is linked to ankylosing spondyloarthritis, and NKC3 C/C and MICA-129 val/val to psoriatic arthritis. MICA and NKC3 polymorphisms (related to a low NK cell cytotoxic activity) constituted a genetic association with spondyloarthritis.
Insights
Genetic variations in MICA and NKC3 influence natural killer cell activity and are associated with spondyloarthritis. Specific MICA alleles and NKC3 genotypes linked to lower NK cell cytotoxicity show a significant association with these inflammatory conditions.
Area of Science:
- Immunogenetics
- Rheumatology
- Molecular Biology
Background:
- The Major Histocompatibility Complex class I polypeptide-related sequence A (MICA) glycoprotein interacts with the Natural Killer Group 2D (NKG2D) receptor, influencing immune responses.
- Polymorphisms in MICA and NKG2D receptor genes, such as MICA-129 and NKC3, affect MICA-NKG2D binding affinity and natural killer (NK) cell cytotoxic activity.
Purpose of the Study:
- To investigate the association between MICA and NKC3 gene polymorphisms and spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis.
- To determine if specific MICA or NKC3 variants correlate with disease susceptibility or specific subtypes of spondyloarthritis.
Main Methods:
- Case-control study comparing 162 spondyloarthritis patients (including ankylosing spondylitis and psoriatic arthritis) with 124 healthy controls.
- Genotyping for MICA-129 (methionine/valine), MICA A5.1 allele, and NKG2D polymorphisms (NKC3 and NKC4).
- Statistical analysis, including odds ratios (OR) and adjusted ORs for HLA-B*27, to assess genetic associations.
Main Results:
- The MICA-129 methionine allele was more frequent in spondyloarthritis patients (OR=4.84).
- MICA-129 val/val, MICA A5.1, and NKC3 C/C variants were less frequent, suggesting a protective effect (ORs ranging from 0.15 to 0.24).
- After adjusting for HLA-B*27, only NKC3 C/C remained significantly associated with spondyloarthritis (adjusted OR=0.14). Homozygosity for MICA A5.1 and NKC3 C/C and MICA-129 val/val were linked to specific subtypes.
Conclusions:
- MICA and NKC3 polymorphisms, particularly those associated with reduced NK cell cytotoxic activity, are genetically linked to spondyloarthritis.
- Specific genotypes like NKC3 C/C and MICA-129 val/val may confer protection against or be associated with specific subtypes of spondyloarthritis.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Histone Variants at the Centromere
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Relative Risk
Transcription Factors
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...


